查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
截骨板全球市場-2022-2029
市場調查報告書
商品編碼
1140750

截骨板全球市場-2022-2029

Global Osteotomy Plates Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

骨病增加推動市場增長

預計骨骼相關疾病發病率的增加將提振市場。骨質疏鬆症等骨病是骨折的常見原因之一。根據國際骨質疏鬆症基金會最近的統計數據，骨質疏鬆症導致全球超過 890 萬例骨折。因此，骨骼疾病發病率的增加正在推動市場。預計老年人口的增加將提振市場。老年人易受各種生理和心理變化的影響，據說容易患關節炎和骨質疏鬆症等與年齡有關的骨病。因此，不斷增長的老年人口將增加對截骨術的需求，並推動截骨板的市場增長。

預計交通事故的增加也將提振市場。根據年度全球道路交通事故統計，每年約有 130 萬人死於道路交通事故。另有 20-5000 萬人受傷或致殘。除非採取行動，否則到 2030 年道路交通傷害將成為第五大死因。因此，由於交通事故的增加，骨外科手術的增加正在推動市場。

近年來截骨板的進步也有望提振市場。鎳鈦諾是一種鎳鈦合金，具有形狀記憶功能，可以在斷裂面上承受壓力。鎳鈦合金釘也可用於截骨術，以確保碎片接近和骨折平面的動態壓縮，並限制骨不連的發生。由於這些優勢，鎳鈦諾釘已成為一種有價值的植入材料，一些製造商已將它們添加到他們的產品組合中。例如，用於 Akin 截骨術的 Arthrex DynaNite Nitinol Staple 就是一個例子。因此，截骨板的最新進展正在推動市場。

然而，截骨術的高成本和與截骨術相關的並發症預計將阻礙市場。與截骨術相關的並發症包括神經損傷、出血、血栓、感染、運動範圍差、疤痕、關節炎的發展以及軟組織和關節的再損傷。

地理滲透。

在預測期內，北美占主導地位。

北美在 2021 年將主導全球截骨板市場，預計在預測期內將保持相當大的市場規模，原因是骨相關疾病的數量不斷增加、骨相關疾病的外科手術數量增加以及消費者對汞的影響。骨病發病率上升預計將提振市場。例如，根據 CDC 的數據，到 2021 年，關節炎將影響美國 24% 的成年人，即約 5850 萬人。這也是導致工作殘疾的主要原因。在美國，關節炎每年的直接醫療費用約為 3035 億美元。因此，骨骼相關疾病發病率的增加正在推動市場。協助管理骨骼相關疾病的政府機構也有望推動市場。例如，由國家骨質疏鬆症基金會 (NOF) 領導的美國骨質疏鬆症倡導團體是致力於骨質疏鬆症和骨骼健康的全國領先的健康組織。NOF 致力於為患者和醫療保健專業人員提供有用的信息和資源，以更好地了解骨質疏鬆症的危險因素、預防和治療、提高質量和患者獲得護理的機會，並推進醫學研究。我在這裡。此外，NOF 的專業項目 BoneSource 促進了所有參與診斷、預防和治療骨質疏鬆症的醫療保健專業人員的臨床卓越護理。因此，政府機構對協助骨骼健康管理的意識增強以及截骨板製造的主要參與者正在推動市場。

競爭格局

在全球截骨板市場運營的主要參與者有 Arthrex, Inc.、Acumed, LLC、Johnson & Johnson、FH Orthopedics、B. Braun Melsungen AG、Zimmer Biomet、Stryker Corporation、Wright Medical Group NV、OrthoPediatrics Corp 和 Amplitude Surgical，等等一些主要參與者正在遵循併購戰略來擴大業務。例如，2020年10月，Olympus Corporation收購了國際骨科公司FH ORTHO SAS。通過此次收購，該公司擴大了其用於韌帶修復、足踝和創傷手術的 MIS 解決方案組合。通過這次擴張，該公司還擴大了在美國和歐洲的業務。2022 年 7 月，Accumed 收購了 Exsomed，以加強其上肢解決方案組合。Exsomed 的產品組合支持髓內方法治療手部骨折，將增強 Accumed 針對簡單到復雜損傷的全面上肢解決方案組合。該公司的產品與 Accumed 廣泛的行業首創手部和腕部解決方案組合非常契合。Exsomed 的產品包括 Innate、InFrame 和 ArrowPhix。2020 年 10 月，Colson Medical, LLC 宣布合併兩家 Colson Medical 公司，Acumed 和 OsteoMed。此次合併將業務重點放在手/上肢、足/踝、創傷（包括胸壁損傷）、顱頜面（CMF）和神經外科（Neuro）、肌腱/韌帶修復和生物外科市場。合併還將擴大產品組合。

全球截骨板市場報告提供對大約 61 個市場數據表、51 個數字和 170 頁的訪問。

目錄

第一章 調查方法和範圍

  • 調查方法
  • 調查目的和範圍

第二章市場定義和概述

第三章執行摘要

  • 按材料分類的市場
  • 按應用劃分的市場細分
  • 最終用戶的市場細分

第 4 章 動力學

  • 市場影響因素
    • 促進者
      • 骨骼相關疾病的發病率增加
      • 老年人口增加
    • 抑製劑
      • 與截骨術相關的潛在並發症
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析
  • 未滿足的需求分析

第 6 章 按材料分類

  • 高分子材料
  • 金屬
    • 鈦
    • 防鏽的
    • 其他

第 7 章 按用途

  • 膝關節手術
    • 通過外科手術
    • 圓頂技術
    • 人字形截骨術
    • 閉楔法
    • 開楔法
    • 其他
  • 髖關節手術
  • 其他

第 8 章最終用戶

  • 醫院
  • 診所
  • 其他

第9章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東/非洲

第 10 章 競爭格局

  • 競爭情景
  • 市場定位/市場份額分析
  • 併購分析

第十一章公司簡介

  • Arthrex, Inc.
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Acumed, LLC
  • Johnson & Johnson
  • FH Orthopedics
  • B. Braun Melsungen AG
  • Zimmer Biomet
  • Stryker Corporation
  • Wright Medical Group N.V.
  • OrthoPediatrics Corp.
  • Amplitude Surgical（"List not exhaustive"）

第 12 章 數據管理

簡介目錄
Product Code: DMPH2027

Market Overview

Osteotomy Plates Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 3.8 % during the forecast period (2022-2029).

Osteotomy plates are used to perform a surgical bone operation called an osteotomy. The procedure is employed to lengthen or shorten the bone alignments to treat bone disorders like osteoarthritis, dysplasia, bone diseases, and bone injuries. The osteotomy plates eliminate the need for intraoperative contouring and reduce soft tissue irritation. They have tapered ends that allow submuscular plate insertion. Also, the locking screws create a fixed-angle construct that provides angular stability. The global osteotomy plates market is driven by an increase in the incidence rate of bone-related disorders, the rising geriatric population susceptible to bone diseases, growing preferences for surgical procedures, and the increasing number of road accidents.

Market Dynamics: Increasing in bone disorder drives market growth

The increasing incidence rate of bone-related disorders is expected to boost the market. Bone disorders such as osteoporosis are one of the common causes of fractures. According to recent statistics from the International Osteoporosis Foundation, osteoporosis causes more than 8.9 million fractures worldwide. Thus, the increasing incidence of bone disorders is driving the market. The rising geriatric population is expected to boost the market. The aged population is more prone to various physical and psychological changes leading to age-associated diseases of bone such as arthritis and osteoporosis. Thus, the increasing geriatric population will upsurge the need for osteotomy procedures, thereby boosting the market growth for osteotomy plates.

Also, the increasing number of road accidents is expected to boost the market. According to the Annual Global Road Crash Statistics, nearly 1.3 million people die in road crashes yearly. Also, an additional 20-50 million are injured or disabled. Unless action is taken, road traffic injuries will become the fifth leading cause of death by 2030. Thus, the increasing numbers of road accidents, leading to increased bone surgeries, are driving the market.

Also, the presence of recent advances in osteotomy plates is expected to boost the market. Nitinol is a nickel-titanium alloy with shape-memory properties, facilitating a continuous compressive force to fracture surfaces. Using Nitinol staples for osteotomy procedures also ensures a good approximation of bone fragments and dynamic compression of fracture surfaces and reduces incidences of nonunion. These advantages make Nitinol staples a valuable implant material, and several manufacturers are adding it to their portfolio. For instance, DynaNite Nitinol Staple for Akin Osteotomy of Arthrex is one of a kind. Thus, the presence of recent advancements in osteotomy plates is driving the market.

However, the high cost of osteotomy procedures and complications associated with the osteotomy process are expected to hamper the market. Complications related to osteotomy procedures include nerve damage, bleeding, blood clots, infections, lack of full range motion, scar formation, development of arthritis, and reinjuries to the soft tissue or joint.

Market Segmentation: The knee surgery plates segment is projected to be the dominant segment in the market during the forecast period.

The global osteotomy plates market is segmented into knee surgery, hip surgery, and other applications.

The knee surgery segment is expected to boost the market owing to the increased adoption of High tibial osteotomy procedures. The increasing prevalence of orthopedic conditions, driven by age, road accidents, and inheritance, is the major driving factor for high tibial osteotomy (HTO) plates worldwide. 3D printing technology is rapidly growing as an attractive option for coupling with HTO to attain superior post-surgery results with the benefit of high accuracy. Thus, the increasing adoption of high tibial osteotomy procedures and the technological advancements in osteotomy drive the market.

The hip surgeries segment held a significant market share in the market. It is due to the increasing prevalence of bone-related diseases and osteotomy procedures in hip surgeries. Abnormal development in the hip joint in adolescents and young adults is more common. The condition may lead to hip dysplasia and hip impingement and usually requires surgery to correct the problem.

Geographical Penetration: North America is the dominating region during the forecast period.

North America is dominating the global osteotomy plates market in 2021 and is estimated to hold a significant market size over the forecast period due to the rising bone-related diseases, increasing surgical procedures for bone-related diseases and hg power of consumers. The rising incidence of bone diseases is expected to boost the market. For instance, according to the CDC, in the US, 24% of all adults, about 58.5 million people, will have arthritis in 2021. Also, it is a leading cause of work disability. The annual direct medical costs for arthritis are approximately $ 303.5 billion in the US. Thus, the increasing incidence of bone-related diseases is driving the market. Also, t government organizations aiding in bone-related disease management are expected to boost the market. For instance, Osteoporosis advocacy in the US, led by the National Osteoporosis Foundation (NOF), is the nation's leading health organization dedicated to osteoporosis and bone health. NOF delivers information and resources to help the patients and health professionals, fosters the understanding of osteoporosis risk factors and the prevention and treatment options, drives quality and patient access to care, and works to advance medical research. Also, BoneSource, a NOF professional program, promotes excellence in clinical care for all the healthcare professionals involved in the diagnosis, prevention, and treatment of osteoporosis. Thus, government organizations aiding bone health management, and increasing awareness among the key players in manufacturing osteotomy plates, are driving the market.

Competitive Landscape:

The key players operating in the global osteotomy plates market are Arthrex, Inc., Acumed, LLC, Johnson & Johnson, FH Orthopedics, B. Braun Melsungen AG, Zimmer Biomet, Stryker Corporation, Wright Medical Group N.V., OrthoPediatrics Corp., and Amplitude Surgical. Some key players follow merger and acquisition strategies to expand their business. For instance, in October 2020, Olympus Corporation acquired FH ORTHO SAS, an international orthopedic company. Through this acquisition, the company expanded its portfolio of MIS solutions for ligament repair, foot and ankle, and trauma surgery. Through this expansion, the company also expanded its presence in the United States and Europe. In July 2022, Acumed acquired ExsoMed to enhance its portfolio of upper extremity solutions. Exsomed has a product portfolio that supports an intramedullary approach to treating hand fractures and enhances Acumed's comprehensive portfolio of upper extremity solutions for simple to complex injuries. The company's products are a natural fit for Acumed's extensive portfolio of industry-first hand and wrist solutions. Some of the Exsomed products include Innate, InFrame, and ArrowPhix. In October 2020, Colson Medical, LLC announced a merger with two Colson Medical companies, Acumed and OsteoMed. Combined, they focused on the business of Hand/Upper Extremity, Foot/Ankle, Trauma (including chest wall injury), Craniomaxillofacial (CMF) and Neurosurgery (Neuro), Tendon/Ligament Repair and Biologics surgical markets. This merger also helps to expand their product portfolio.

The global osteotomy plate's market report would provide an access to approximately 61 market data tables, 51 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Material
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-user

4. Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising incidence of bone-related diseases
      • 4.1.1.2. The increasing number of geriatric population
    • 4.1.2. Restraints
      • 4.1.2.1. The possible complications associated with osteotomy procedures
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material Segment
  • 6.2. Polymers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
  • 6.3. Metals
    • 6.3.1. Introduction
    • 6.3.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
      • 6.3.2.1. Titanium
      • 6.3.2.2. Stainless steel
      • 6.3.2.3. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Knee surgery*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
      • 7.2.2.1. By technique
      • 7.2.2.1.1. Dome Technique
      • 7.2.2.1.2. Chevron Osteotomy
      • 7.2.2.1.3. Closed Wedge Technique
      • 7.2.2.1.4. Open Wedge Technique
      • 7.2.2.1.5. Others
  • 7.3. Hip surgery
  • 7.4. Others

8. By End-user

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
    • 8.1.2. Market Attractiveness Index, By End-user Segment
  • 8.2. Hospitals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
  • 8.3. Clinics
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. The U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. The U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. The Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Arthrex, Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Acumed, LLC
  • 11.3. Johnson & Johnson
  • 11.4. FH Orthopedics
  • 11.5. B. Braun Melsungen AG
  • 11.6. Zimmer Biomet
  • 11.7. Stryker Corporation
  • 11.8. Wright Medical Group N.V.
  • 11.9. OrthoPediatrics Corp.
  • 11.10. Amplitude Surgical ("List not exhaustive")

12. Data M

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us